$ATNM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Actinium Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Actinium Pharmaceuticals, Inc.. Get notifications about new insider transactions in Actinium Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | O'Loughlin Steve | Chief Financial Off ... | Option Exercise | A | 9.55 | 59,066 | 564,080 | 59,066 | |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chief Executive Off ... | Option Exercise | A | 9.55 | 139,062 | 1,328,042 | 139,062 | |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Chell Jeffrey W. | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | A | 9.55 | 46,667 | 445,670 | 46,667 | |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Shetty Ajit | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Ludwig Dale L. | Chief Science & Tec ... | Option Exercise | A | 9.55 | 50,000 | 477,500 | 50,000 | |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Nicholson, C. David | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 0.23 | 250,000 | 58,000 | 250,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Chell Jeffrey W. | Director | Option Exercise | A | 0.23 | 250,000 | 58,000 | 250,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Ludwig Dale L. | Chief Scientific Of ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Option Exercise | A | 0.23 | 1,500,000 | 348,000 | 1,500,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Kapur Anil | Chief Commercial Of ... | Option Exercise | A | 0.23 | 400,000 | 92,800 | 400,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Shetty Ajit | Director | Option Exercise | A | 0.23 | 250,000 | 58,000 | 250,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Nicholson, C. David | Director | Option Exercise | A | 0.23 | 250,000 | 58,000 | 250,000 | |
| Mar 07 2019 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Buy | X | 0.60 | 3,500 | 2,100 | 22,500 | 19 K to 22.5 K (+18.42 %) |
| Feb 21 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | X | 0.60 | 8,125 | 4,875 | 161,458 | 153.3 K to 161.5 K (+5.30 %) |
| Feb 21 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | X | 0.60 | 8,125 | 4,875 | 161,458 | 153.3 K to 161.5 K (+5.30 %) |
| Dec 10 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | P | 0.44 | 10,000 | 4,372 | 153,333 | 143.3 K to 153.3 K (+6.98 %) |
| Dec 10 2018 | ATNM | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Buy | P | 0.44 | 10,000 | 4,350 | 35,500 | 25.5 K to 35.5 K (+39.22 %) |
| Nov 20 2018 | ATNM | Actinium Pharmaceu ... | Ludwig Dale L. | Chief Scientific Of ... | Buy | P | 0.45 | 10,000 | 4,499 | 10,000 | 0 to 10 K |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | Nicholson, C. David | Director | Option Exercise | A | 0.78 | 75,000 | 58,718 | 75,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | Chell Jeffrey W. | Director | Option Exercise | A | 0.78 | 75,000 | 58,718 | 75,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | Ray Nitya G. | Executive VP | Option Exercise | A | 0.78 | 75,000 | 58,718 | 75,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | A | 0.78 | 250,000 | 195,725 | 250,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Option Exercise | A | 0.78 | 1,000,000 | 782,900 | 1,000,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Buy | P | 0.79 | 10,000 | 7,900 | 143,333 | 133.3 K to 143.3 K (+7.50 %) |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Option Exercise | A | 0.78 | 265,000 | 207,469 | 265,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | Shetty Ajit | Director | Option Exercise | A | 0.78 | 75,000 | 58,718 | 75,000 | |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 0.78 | 75,000 | 58,718 | 75,000 | |
| Jun 15 2018 | ATNM | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Buy | P | 0.50 | 12,000 | 6,000 | 25,500 | 13.5 K to 25.5 K (+88.89 %) |
| Apr 20 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | P | 0.38 | 5,000 | 1,900 | 133,333 | 128.3 K to 133.3 K (+3.90 %) |
| Mar 19 2018 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | J | 0.70 | 10,500 | 7,350 | 10,500 | |
| Mar 19 2018 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | J | 0.60 | 3,500 | 2,100 | 3,500 | |
| Mar 19 2018 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Buy | J | 0.50 | 14,000 | 7,000 | 19,000 | 5 K to 19 K (+280.00 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Option Exercise | J | 0.70 | 39,375 | 27,563 | 39,375 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Option Exercise | J | 0.60 | 13,125 | 7,875 | 13,125 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | J | 0.50 | 52,500 | 26,250 | 128,333 | 75.8 K to 128.3 K (+69.23 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Ray Nitya G. | Executive VP | Option Exercise | J | 0.70 | 7,500 | 5,250 | 7,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Ray Nitya G. | Executive VP | Option Exercise | J | 0.60 | 2,500 | 1,500 | 2,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Ray Nitya G. | Executive VP | Buy | J | 0.50 | 10,000 | 5,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | J | 0.70 | 5,250 | 3,675 | 5,250 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | J | 0.60 | 1,750 | 1,050 | 1,750 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Buy | J | 0.50 | 7,000 | 3,500 | 9,500 | 2.5 K to 9.5 K (+280.00 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Option Exercise | J | 0.70 | 7,500 | 5,250 | 7,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Option Exercise | J | 0.60 | 2,500 | 1,500 | 2,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Buy | J | 0.50 | 10,000 | 5,000 | 13,500 | 3.5 K to 13.5 K (+285.71 %) |
| Mar 01 2018 | CTVN | Actinium Pharmaceu ... | Shetty Ajit | Director | Buy | P | 0.43 | 22,730 | 9,774 | 22,730 | 0 to 22.7 K |
| Aug 04 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | P | 0.75 | 33,333 | 25,000 | 75,833 | 42.5 K to 75.8 K (+78.43 %) |
| Aug 04 2017 | CTVN | Actinium Pharmaceu ... | Ray Nitya G. | Executive Vice Pres ... | Buy | P | 0.75 | 10,000 | 7,500 | 10,000 | 0 to 10 K |
| Jun 15 2017 | CTVN | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Buy | P | 1.11 | 5,000 | 5,550 | 5,000 | 0 to 5 K |
| Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.16 | 5,000 | 5,800 | 42,500 | 37.5 K to 42.5 K (+13.33 %) |
| Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.16 | 5,000 | 5,800 | 42,500 | 37.5 K to 42.5 K (+13.33 %) |
| Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.17 | 2,500 | 2,925 | 37,500 | 35 K to 37.5 K (+7.14 %) |
| Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.17 | 2,500 | 2,925 | 37,500 | 35 K to 37.5 K (+7.14 %) |
| Jun 15 2017 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Buy | P | 1.17 | 3,500 | 4,095 | 3,500 | 0 to 3.5 K |
| Jun 15 2017 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Buy | P | 1.17 | 3,500 | 4,095 | 3,500 | 0 to 3.5 K |
| Mar 16 2017 | CTVN | Actinium Pharmaceu ... | DAVE KAUSHIK J | CEO and Interim CFO | Option Exercise | A | 1.39 | 250,000 | 347,500 | 250,000 | |
| Mar 16 2017 | CTVN | Actinium Pharmaceu ... | TRAVERSA SERGIO | Director | Option Exercise | A | 1.39 | 75,000 | 104,250 | 75,000 | |
| Mar 16 2017 | CTVN | Actinium Pharmaceu ... | Nicholson, C. David | Director | Option Exercise | A | 1.39 | 75,000 | 104,250 | 75,000 | |
| Mar 16 2017 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 1.39 | 75,000 | 104,250 | 75,000 | |
| Mar 16 2017 | CTVN | Actinium Pharmaceu ... | CICIC DRAGAN | Chief Technology Of ... | Option Exercise | A | 1.39 | 75,000 | 104,250 | 75,000 | |
| Jan 03 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Executive Chairman | Buy | P | 0.88 | 5,000 | 4,400 | 35,000 | 30 K to 35 K (+16.67 %) |
| Dec 12 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Executive Chairman | Buy | P | 0.98 | 5,000 | 4,900 | 30,000 | 25 K to 30 K (+20.00 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.87 | 14,165 | 26,489 | 4,709,561 | 4.7 M to 4.7 M (-0.30 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.86 | 9,800 | 18,228 | 4,723,726 | 4.7 M to 4.7 M (-0.21 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.85 | 40,200 | 74,370 | 4,733,526 | 4.8 M to 4.7 M (-0.84 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.84 | 15,000 | 27,600 | 4,773,726 | 4.8 M to 4.8 M (-0.31 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 800 | 1,464 | 4,788,726 | 4.8 M to 4.8 M (-0.02 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 25,100 | 45,682 | 4,789,526 | 4.8 M to 4.8 M (-0.52 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 200 | 363 | 4,814,626 | 4.8 M to 4.8 M (0.00 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 6,400 | 11,584 | 4,814,826 | 4.8 M to 4.8 M (-0.13 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 25,188 | 45,338 | 4,821,226 | 4.8 M to 4.8 M (-0.52 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 100 | 182 | 4,846,414 | 4.8 M to 4.8 M (0.00 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 300 | 545 | 4,846,514 | 4.8 M to 4.8 M (-0.01 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 200 | 363 | 4,846,814 | 4.8 M to 4.8 M (0.00 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 30,474 | 55,158 | 4,847,014 | 4.9 M to 4.8 M (-0.62 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 1,500 | 2,708 | 4,877,488 | 4.9 M to 4.9 M (-0.03 %) |
| Sep 01 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 23,500 | 42,300 | 4,878,988 | 4.9 M to 4.9 M (-0.48 %) |
| Aug 30 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.72 | 12,500 | 21,500 | 4,902,488 | 4.9 M to 4.9 M (-0.25 %) |
| Aug 30 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.71 | 12,500 | 21,375 | 4,914,988 | 4.9 M to 4.9 M (-0.25 %) |
| Aug 30 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.71 | 12,002 | 20,523 | 4,927,488 | 4.9 M to 4.9 M (-0.24 %) |
| Aug 30 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.70 | 12,998 | 22,097 | 4,939,490 | 5 M to 4.9 M (-0.26 %) |
| Aug 17 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.73 | 400 | 690 | 4,952,488 | 5 M to 5 M (-0.01 %) |
| Aug 17 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.72 | 4,629 | 7,962 | 4,952,888 | 5 M to 5 M (-0.09 %) |
| Aug 17 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.72 | 4,439 | 7,635 | 4,957,517 | 5 M to 5 M (-0.09 %) |
| Jul 14 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 100 | 181 | 4,961,956 | 5 M to 5 M (0.00 %) |
| Jul 14 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 3,000 | 5,400 | 4,962,056 | 5 M to 5 M (-0.06 %) |
| Jul 12 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 800 | 1,440 | 4,965,056 | 5 M to 5 M (-0.02 %) |
| Jul 12 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 21,190 | 38,142 | 4,965,856 | 5 M to 5 M (-0.42 %) |
| Jul 07 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 10,500 | 18,900 | 4,987,046 | 5 M to 5 M (-0.21 %) |
| Jul 07 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 4,340 | 7,942 | 4,997,546 | 5 M to 5 M (-0.09 %) |
| Jul 07 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 6,000 | 10,920 | 5,001,886 | 5 M to 5 M (-0.12 %) |
| Jul 07 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 10,500 | 18,900 | 4,987,046 | 5 M to 5 M (-0.21 %) |
| Jul 07 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 4,340 | 7,942 | 4,997,546 | 5 M to 5 M (-0.09 %) |
| Jul 07 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 6,000 | 10,920 | 5,001,886 | 5 M to 5 M (-0.12 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.91 | 300 | 573 | 5,007,886 | 5 M to 5 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.90 | 100 | 190 | 5,008,186 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.88 | 2,550 | 4,794 | 5,008,286 | 5 M to 5 M (-0.05 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.87 | 1,700 | 3,179 | 5,010,836 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.87 | 1,400 | 2,611 | 5,012,536 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.86 | 5,900 | 10,974 | 5,013,936 | 5 M to 5 M (-0.12 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.86 | 100 | 186 | 5,019,836 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.85 | 3,617 | 6,691 | 5,019,936 | 5 M to 5 M (-0.07 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 700 | 1,281 | 5,023,553 | 5 M to 5 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 1,400 | 2,555 | 5,024,253 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 13,830 | 25,171 | 5,025,653 | 5 M to 5 M (-0.27 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 4,300 | 7,805 | 5,039,483 | 5 M to 5 M (-0.09 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 200 | 362 | 5,043,793 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.91 | 300 | 573 | 5,007,886 | 5 M to 5 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 7,362 | 13,326 | 5,043,983 | 5.1 M to 5 M (-0.15 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.90 | 100 | 190 | 5,008,186 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 25,800 | 46,698 | 5,051,345 | 5.1 M to 5.1 M (-0.51 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.88 | 2,550 | 4,794 | 5,008,286 | 5 M to 5 M (-0.05 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 11,350 | 20,487 | 5,077,145 | 5.1 M to 5.1 M (-0.22 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.87 | 1,700 | 3,179 | 5,010,836 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 100 | 180 | 5,088,495 | 5.1 M to 5.1 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.87 | 1,400 | 2,611 | 5,012,536 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 200 | 360 | 5,088,595 | 5.1 M to 5.1 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.86 | 5,900 | 10,974 | 5,013,936 | 5 M to 5 M (-0.12 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 3,200 | 5,760 | 5,088,795 | 5.1 M to 5.1 M (-0.06 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.86 | 100 | 186 | 5,019,836 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 44,841 | 80,714 | 5,091,995 | 5.1 M to 5.1 M (-0.87 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.85 | 3,617 | 6,691 | 5,019,936 | 5 M to 5 M (-0.07 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 3,350 | 6,097 | 5,136,836 | 5.1 M to 5.1 M (-0.07 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 700 | 1,281 | 5,023,553 | 5 M to 5 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 300 | 542 | 5,140,186 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 1,400 | 2,555 | 5,024,253 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.91 | 300 | 573 | 5,007,886 | 5 M to 5 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 300 | 541 | 5,140,486 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 13,830 | 25,171 | 5,025,653 | 5 M to 5 M (-0.27 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.90 | 100 | 190 | 5,008,186 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 15,200 | 27,360 | 5,140,786 | 5.2 M to 5.1 M (-0.29 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.82 | 4,300 | 7,805 | 5,039,483 | 5 M to 5 M (-0.09 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.88 | 2,550 | 4,794 | 5,008,286 | 5 M to 5 M (-0.05 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 200 | 362 | 5,043,793 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.87 | 1,700 | 3,179 | 5,010,836 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 7,362 | 13,326 | 5,043,983 | 5.1 M to 5 M (-0.15 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.87 | 1,400 | 2,611 | 5,012,536 | 5 M to 5 M (-0.03 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 25,800 | 46,698 | 5,051,345 | 5.1 M to 5.1 M (-0.51 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.86 | 5,900 | 10,974 | 5,013,936 | 5 M to 5 M (-0.12 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.81 | 11,350 | 20,487 | 5,077,145 | 5.1 M to 5.1 M (-0.22 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.86 | 100 | 186 | 5,019,836 | 5 M to 5 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 100 | 180 | 5,088,495 | 5.1 M to 5.1 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.85 | 3,617 | 6,691 | 5,019,936 | 5 M to 5 M (-0.07 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.80 | 200 | 360 | 5,088,595 | 5.1 M to 5.1 M (0.00 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 700 | 1,281 | 5,023,553 | 5 M to 5 M (-0.01 %) |
| Jul 05 2016 | CTVN | Actinium Pharmaceu ... | Memorial Sloan-Kettering Cance ... | 10% Owner | Sell | S | 1.83 | 1,400 | 2,555 | 5,024,253 | 5 M to 5 M (-0.03 %) |